The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

(2023) Zobair M. Younossi et al.   HEPATOLOGY

Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial

(2023) Ornella Verrastro et al.   LANCET

Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study

(2023) Matina Kouvari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study

(2022) Seung Min Chung et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort

(2022) Jacob V. DiBattista et al.   DIGESTIVE DISEASES AND SCIENCES

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study

(2022) Jiyun Park et al.   Cardiovascular Diabetology

Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study

(2022) Matina Kouvari et al.   CLINICAL NUTRITION

Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease

(2022) Jeong Woo Kim et al.   Quantitative Imaging in Medicine and Surgery

Association of fatty liver index with all-cause and disease-specific mortality: A nationwide cohort study

(2022) Goh Eun Chung et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

(2022) Michael H. Le et al.   Clinical and Molecular Hepatology

The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study

(2022) Goh Eun Chung et al.   Cardiovascular Diabetology

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV , a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

(2022) Karen D. Corbin et al.   DIABETES OBESITY & METABOLISM

The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study

(2022) Jiyun Park et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study

(2021) Chang-Hoon Lee et al.   Frontiers in Endocrinology

Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank

(2021) Biyao Zou et al.   DIGESTIVE DISEASES AND SCIENCES

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

(2021) Joon Ho Moon et al.   Journal of Cachexia Sarcopenia and Muscle

The association of hepatic steatosis and fibrosis with heart failure and mortality

(2021) Jiyun Park et al.   Cardiovascular Diabetology

The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study

(2021) Matina Kouvari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study

(2020) Jun Hyung Kim et al.   Cardiovascular Diabetology

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

(2020) Beth A. Davison et al.   JOURNAL OF HEPATOLOGY

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

(2020) Amélio F. Godoy-Matos et al.   Diabetology & Metabolic Syndrome

The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective

(2020) Amr Dokmak et al.   AMERICAN JOURNAL OF MEDICINE

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction

(2018) Olubunmi O. Olubamwo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Liver fat scores predict liver disease mortality in the United States population

(2018) Aynur Unalp-Arida et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

(2017) Chris Estes et al.   HEPATOLOGY

The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

(2017) Shujun Zhang et al.   Lipids in Health and Disease

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

(2014) L. Fedchuk et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A simple index of lipid overaccumulation is a good marker of liver steatosis

(2010) Giorgio Bedogni et al.   BMC GASTROENTEROLOGY

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

(2009) Anna Kotronen et al.   GASTROENTEROLOGY